Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial

Journal: Lancet HIV

Volume: 

Issue: 

Year of Publication: 2018

Affiliated Institutions: 

Abstract summary 

Authors & Co-authors: 

Study Outcome 

Source Link: Visit source

Statistics
Citations :  2
Authors :  0
Identifiers
Doi : 10.1016/S2352-3018(18)30257-1
SSN : 
Study Population
Male,Female
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
190
Publication Country